학술논문
BENEFIT–RISK PROFILES OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) VS UMEC/VI IN PATIENTS WITH COPD: A MARKOV MODEL
Document Type
Abstract
Author
Source
In Chest October 2020 158(4) Supplement:A1666-A1671
Subject
Language
ISSN
0012-3692